Stockreport

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Aura Biosciences, Inc.  (AURA) 
PDF Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; Supports Front-Line Trea [Read more]